• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于执行功能的综合评分,在阿尔茨海默病神经影像学倡议(ADNI)的轻度认知障碍基线参与者中得到验证。

A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

机构信息

Harborview Medical Center, University of Washington, Box 359780, 325 Ninth Avenue, Seattle, WA 98104, USA.

出版信息

Brain Imaging Behav. 2012 Dec;6(4):517-27. doi: 10.1007/s11682-012-9176-1.

DOI:10.1007/s11682-012-9176-1
PMID:22644789
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3684181/
Abstract

The Alzheimer's Disease Neuroimaging Initiative (ADNI) measures abilities broadly related to executive function (EF), including WAIS-R Digit Symbol Substitution, Digit Span Backwards, Trails A and B, Category Fluency, and Clock Drawing. This study investigates whether a composite executive function measure based on these multiple indicators has better psychometric characteristics than the widely used individual components. We applied item response theory methods to 800 ADNI participants to derive an EF composite score (ADNI-EF) from the above measures. We then compared ADNI-EF with component measures in 390 longitudinally-followed participants with mild cognitive impairment (MCI) with respect to: (1) Ability to detect change over time; (2) Ability to predict conversion to dementia; (3) Strength of cross-sectional association with MRI-derived measures of structures involved in frontal systems, and (4) Strength of baseline association with cerebrospinal fluid (CSF) levels of amyloid β₁₋₄₂, total tau, and phosphorylated tau(181P). ADNI-EF showed the greatest change over time, followed closely by Category Fluency. ADNI-EF needed a 40 % smaller sample size to detect change. ADNI-EF was the strongest predictor of AD conversion. ADNI-EF was the only measure significantly associated with all the MRI regions, though other measures were more strongly associated in a few of the regions. ADNI-EF was associated with all the CSF measures. ADNI-EF appears to be a useful composite measure of EF in MCI, as good as or better than any of its composite parts. This study demonstrates an approach to developing a psychometrically sophisticated composite score from commonly-used tests.

摘要

阿尔茨海默病神经影像学倡议 (ADNI) 测量了广泛与执行功能 (EF) 相关的能力,包括 WAIS-R 数字符号替换、数字广度倒背、Trails A 和 B、类别流畅性和时钟绘制。本研究探讨了基于这些多个指标的综合执行功能测量是否比广泛使用的单个成分具有更好的心理测量特征。我们应用项目反应理论方法对 800 名 ADNI 参与者进行分析,从上述测量中得出一个 EF 综合评分(ADNI-EF)。然后,我们在 390 名轻度认知障碍 (MCI) 的纵向随访参与者中比较了 ADNI-EF 与成分测量,以评估以下方面:(1) 随时间变化的检测能力;(2) 预测向痴呆转化的能力;(3) 与涉及额系统的 MRI 测量结构的横断面关联强度;(4) 与脑脊液 (CSF) 中淀粉样蛋白 β₁₋₄₂、总 tau 和磷酸化 tau(181P)水平的基线关联强度。ADNI-EF 显示出最大的时间变化,紧随其后的是类别流畅性。ADNI-EF 检测变化所需的样本量比其他成分测量小 40%。ADNI-EF 是 AD 转化的最强预测因子。ADNI-EF 是唯一与所有 MRI 区域都显著相关的测量指标,尽管其他指标在少数区域的关联更强。ADNI-EF 与所有 CSF 测量指标都显著相关。ADNI-EF 似乎是 MCI 中 EF 的一种有用的综合测量指标,与任何成分测量一样好或更好。本研究展示了一种从常用测试中开发出心理测量上复杂的综合评分的方法。

相似文献

1
A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.用于执行功能的综合评分,在阿尔茨海默病神经影像学倡议(ADNI)的轻度认知障碍基线参与者中得到验证。
Brain Imaging Behav. 2012 Dec;6(4):517-27. doi: 10.1007/s11682-012-9176-1.
2
The Alzheimer's Disease Assessment Scale-Cognitive-Plus (ADAS-Cog-Plus): an expansion of the ADAS-Cog to improve responsiveness in MCI.阿尔茨海默病评估量表-认知加项(ADAS-Cog-Plus):ADAS-Cog 的扩展,以提高 MCI 的反应性。
Brain Imaging Behav. 2012 Dec;6(4):489-501. doi: 10.1007/s11682-012-9166-3.
3
Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).发展和评估阿尔茨海默病神经影像学倡议 (ADNI) 中记忆的综合评分。
Brain Imaging Behav. 2012 Dec;6(4):502-16. doi: 10.1007/s11682-012-9186-z.
4
Confirmatory factor analysis of the ADNI Neuropsychological Battery.ADNI 神经心理学成套测验的验证性因子分析。
Brain Imaging Behav. 2012 Dec;6(4):528-39. doi: 10.1007/s11682-012-9190-3.
5
Cortical signatures of cognition and their relationship to Alzheimer's disease.认知的皮质特征及其与阿尔茨海默病的关系。
Brain Imaging Behav. 2012 Dec;6(4):584-98. doi: 10.1007/s11682-012-9180-5.
6
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病患者记忆和执行功能缺陷的体素和表面拓扑结构。
Brain Imaging Behav. 2012 Dec;6(4):551-67. doi: 10.1007/s11682-012-9203-2.
7
Longitudinal change in neuropsychological performance using latent growth models: a study of mild cognitive impairment.采用潜在增长模型的神经心理学表现的纵向变化:轻度认知障碍研究。
Brain Imaging Behav. 2012 Dec;6(4):540-50. doi: 10.1007/s11682-012-9161-8.
8
Development and validation of the Uniform Data Set (v3.0) executive function composite score (UDS3-EF).开发和验证统一数据集中(v3.0 版)执行功能综合评分(UDS3-EF)。
Alzheimers Dement. 2021 Apr;17(4):574-583. doi: 10.1002/alz.12214. Epub 2020 Nov 20.
9
Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.认知储备与阿尔茨海默病的临床进展:一种矛盾的关系。
Neurology. 2019 Jul 23;93(4):e334-e346. doi: 10.1212/WNL.0000000000007821. Epub 2019 Jul 2.
10
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.肝酶改变与阿尔茨海默病诊断、认知、神经影像学指标和脑脊液生物标志物的关联。
JAMA Netw Open. 2019 Jul 3;2(7):e197978. doi: 10.1001/jamanetworkopen.2019.7978.

引用本文的文献

1
Prediction of cognitive decline and Alzheimer's disease conversion by a plasma biomarker panel in non-demented individuals.通过血浆生物标志物组合预测非痴呆个体的认知衰退和阿尔茨海默病转化
Geroscience. 2025 Sep 6. doi: 10.1007/s11357-025-01869-2.
2
Neuroinflammation-mediated YKL-40 correlates with tau pathology and predicts longitudinal cognitive impairment and brain atrophy in Alzheimer's disease, with hypertensive dependency.神经炎症介导的YKL-40与tau病理相关,并预测阿尔茨海默病患者的纵向认知障碍和脑萎缩,且与高血压相关。
Front Aging Neurosci. 2025 Aug 6;17:1630022. doi: 10.3389/fnagi.2025.1630022. eCollection 2025.
3

本文引用的文献

1
Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.阿尔茨海默病神经影像倡议中生物标志物、认知标志物和风险因素组合对预测轻度认知障碍患者向阿尔茨海默病转化的效用
Arch Gen Psychiatry. 2011 Sep;68(9):961-9. doi: 10.1001/archgenpsychiatry.2011.96.
2
Executive dysfunction in mild cognitive impairment is associated with changes in frontal and cingulate white matter tracts.轻度认知障碍中的执行功能障碍与额顶叶和扣带回白质束的变化有关。
J Alzheimers Dis. 2011;27(2):453-62. doi: 10.3233/JAD-2011-110290.
3
Plasma neurofilament light reflects more severe manifestation of Alzheimer's disease in men.
血浆神经丝轻链反映出男性阿尔茨海默病更严重的表现。
Mol Psychiatry. 2025 Aug 12. doi: 10.1038/s41380-025-03149-z.
4
Sex differences in the association between episodic memory residual reserve index and change in executive function.情景记忆残余储备指数与执行功能变化之间关联的性别差异。
Aging Brain. 2025 Jul 31;8:100146. doi: 10.1016/j.nbas.2025.100146. eCollection 2025.
5
Functional Connectome of Superagers Reveals Early Markers of Resilience and Vulnerability to Alzheimer's Disease.超级长寿者的功能连接组揭示了对阿尔茨海默病的恢复力和易感性的早期标志物。
bioRxiv. 2025 Jul 22:2025.07.20.665707. doi: 10.1101/2025.07.20.665707.
6
Sex-specific association of depressive symptom trajectories with cognitive decline and clinical progression in mild cognitive impairment.轻度认知障碍中抑郁症状轨迹与认知衰退及临床进展的性别特异性关联
Alzheimers Dement. 2025 Aug;21(8):e70548. doi: 10.1002/alz.70548.
7
In Vivo Cortical Microstructure: Relationships With Tauopathy and Cognitive Impairment in the Elderly.体内皮质微结构:与老年人 Tau 蛋白病及认知障碍的关系
J Neurochem. 2025 Aug;169(8):e70167. doi: 10.1111/jnc.70167.
8
Hypometabolic subtypes of AD are linked to comorbid hippocampal sclerosis and Lewy body pathology.阿尔茨海默病的低代谢亚型与合并的海马硬化和路易体病理改变有关。
Alzheimers Res Ther. 2025 Jul 25;17(1):172. doi: 10.1186/s13195-025-01796-6.
9
Longitudinal changes in grey matter and cognitive performance over four years of healthy aging.健康衰老四年间灰质和认知能力的纵向变化。
Neuroimage Rep. 2022 Oct 17;2(4):100140. doi: 10.1016/j.ynirp.2022.100140. eCollection 2022 Dec.
10
Functional redundancy of the posterior hippocampi is selectively disrupted in non-demented older adults with -amyloid deposition.在患有淀粉样蛋白沉积的非痴呆老年人中,后海马体的功能冗余被选择性破坏。
Neuroimage Rep. 2025 Mar 23;5(2):100255. doi: 10.1016/j.ynirp.2025.100255. eCollection 2025 Jun.
Executive function mediates effects of white matter hyperintensities on episodic memory.
执行功能介导脑白质高信号对情景记忆的影响。
Neuropsychologia. 2011 Aug;49(10):2817-24. doi: 10.1016/j.neuropsychologia.2011.06.003. Epub 2011 Jun 13.
4
Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.β淀粉样蛋白 42 与健康老年人的认知障碍和主观认知障碍有关。
J Alzheimers Dis. 2011;26(1):135-42. doi: 10.3233/JAD-2011-110038.
5
Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology.最大脑容量仍然是老年认知能力的一个重要预测指标,与当前的大脑病理无关。
Neurobiol Aging. 2012 Aug;33(8):1758-68. doi: 10.1016/j.neurobiolaging.2011.03.017. Epub 2011 May 4.
6
Correlations between MRI white matter lesion location and executive function and episodic memory.MRI 脑白质病变部位与执行功能和情景记忆的相关性。
Neurology. 2011 Apr 26;76(17):1492-9. doi: 10.1212/WNL.0b013e318217e7c8.
7
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance.基于生物标志物和神经心理学测试表现预测轻度认知障碍向阿尔茨海默病痴呆的转化。
Neurobiol Aging. 2012 Jul;33(7):1203-14. doi: 10.1016/j.neurobiolaging.2010.10.019. Epub 2010 Dec 14.
8
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative.阿尔茨海默病神经影像计划第一年中白质病变与认知的纵向变化
Arch Neurol. 2010 Nov;67(11):1370-8. doi: 10.1001/archneurol.2010.284.
9
Cognitive profiles of incipient dementia in the Goteborg MCI study.哥德堡轻度认知损伤研究中初期痴呆的认知特征。
Dement Geriatr Cogn Disord. 2010;30(5):403-10. doi: 10.1159/000321352. Epub 2010 Oct 23.
10
Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease.基于树状多元分析的新型 ADAS-cog 综合评分的推导:从轻度认知障碍到阿尔茨海默病转化的预测。
Alzheimer Dis Assoc Disord. 2011 Jan-Mar;25(1):73-84. doi: 10.1097/WAD.0b013e3181f5b8d8.